## Abstract Vascular endothelial growth factor receptor 1 (VEGFRβ1) is present on endothelial cells and subsets of human tumor cells, raising the hypothesis that angiogenic factors may promote tumor growth both by inducing angiogenesis and directly signaling through activation of VEGFRβ1 on tumor c
Co-Expression of Vascular Endothelial Growth Factor and Interleukin-1 Receptor Antagonist Improves Human Islet Survival and Function
β Scribed by Ajit S. Narang; Omaima Sabek; Ahmed O. Gaber; Ram I. Mahato
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 703 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0724-8741
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present study was to evaluate the expression of VEGF and of its two high-affinity tyrosine kinase receptors (KDR and Flt-
## Abstract The human vascular endothelial growth factor receptorβ1 (VEGFRβ1, or Fltβ1) is widely expressed in normal and pathologic tissue and contributes to the pathogenesis of both neoplastic and inflammatory diseases. In human cancer, VEGFRβ1 mediated signaling is responsible for both direct tu
## Abstract ## BACKGROUND It was recently shown that neuropilinβ1 (NRPβ1), which was described originally as a receptor for the semaphorins/collapsins (ligands involved in neuronal guidance), is a coreceptor for vascular endothelial growth factor (VEGF) and increases the affinity of specific isofo